Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04211935 · ClinicalTrials.gov registry record · NA
Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum
A NA study, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT04211935: Active NA study, sponsored by University of Colorado, Denver.
NCT04211935 is a NA study that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 158 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04211935, a NA study, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
Pectus excavatum is the most common chest wall deformity in children, accounting for 90% of all congenital chest wall deformities. It occurs in one to eight per 1000 live births. The severity of the pectus deformity may become more noticeable during pubertal growth spurs and repair is therefore usually performed in the teenage years. A common operative procedure to repair a pectus deformity is the minimally invasive repair of pectus excavatum (MIRPE). The MIRPE involves the substernal placement of a contoured metal bar secured to the lateral aspect of the ribs. This metal bar allows for correction of the concave deformity by applying constant outward pressure to the underside of the sternum. Although the cosmetic results are excellent, patients do report significant pain from the constant pressure exerted on the chest wall from the metal bar. Pain management approaches tend to differ on both the provider and institutional level. There is a lack of evidence regarding which postoperative analgesia method is best. To address this research gap, this proposal aims to conduct a randomized controlled trail using the three most commonly used methods; 1) patient controlled analgesia (PCA); 2) erector spinae blocks (ESB) with continuous infusion pumps; and 3) video-assisted intercostal nerve cryoablation (INC).
Primary Outcome
The investigators will measure the total length of stay following the operation until discharge from the hospital.
Interventions
- DEVICE Use of PCA
- DEVICE Use of ESB for postoperative pain control after MIRPE
- DEVICE Use of INC for postoperative pain control after MIRPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2020-05-27 |
| Est. Completion | 2027-12 |
| Phase | NA |
What the registry record for NCT04211935 still lists
NCT04211935 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Use of PCA is the first listed.
NCT04211935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04211935 about?
NCT04211935 is a clinical study titled "Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum". Pectus excavatum is the most common chest wall deformity in children, accounting for 90% of all congenital chest wall deformities. It occurs in one to eight per 1000 live births. The severity of the pectus deformity may become more noticeable during pubertal growth spurs and repair is therefore usua...
What is the current status of trial NCT04211935?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 158 participants. The study started on 2020-05-27. Estimated completion is 2027-12.
What interventions are being tested in trial NCT04211935?
The interventions under investigation include: Use of PCA (DEVICE), Use of ESB for postoperative pain control after MIRPE (DEVICE), Use of INC for postoperative pain control after MIRPE (DEVICE).
Who is sponsoring clinical trial NCT04211935?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04211935's enrollment target sits among peer trials
158 654th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI